Perfusion conditioning of hydroxyapatite-chitosan-gelatin scaffolds for bone tissue regeneration from human mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 1, 2012, Pages 49-59

  Sellgren, Katelyn L ^a   Ma, Teng ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Bone construct; Chitosan; Composite scaffold; HMSCs; Human mesenchymal stem cells; Hydroxyapatite

Indexed keywords

BIOMIMETICS; BONE; CELL CULTURE; CROSSLINKING; HYDROXYAPATITE; PHASE SEPARATION; PORE SIZE; PROTEINS; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE REGENERATION;

BONE GRAFT; BONE TISSUE REGENERATION; BONE-CONSTRUCTS; CELL PROLIFERATION/DIFFERENTIATION; CHITOSAN-GELATIN SCAFFOLDS; COMPOSITE SCAFFOLDS; HMSC; HUMAN MESENCHYMAL STEM CELLS; OSTEOGENIC DIFFERENTIATION; TISSUE-ENGINEERED BONES;

CHITOSAN;

CHITOSAN; GELATIN; HYDROXYAPATITE;

ADSORPTION; ARTICLE; BONE TISSUE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELLULAR DISTRIBUTION; EXTRACELLULAR MATRIX; FREEZING; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHASE SEPARATION; PRIORITY JOURNAL; ROOM TEMPERATURE; TISSUE PERFUSION; TISSUE REGENERATION;

EID: 81455140244     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.396     Document Type: Article

References (47)

1. Alvarez-Barreto JF, Linehan SM, Shambaugh RL, et al. 2007; Flow perfusion improves seeding of tissue engineering scaffolds with different architectures. Ann Biomed Eng 35: 429-442.
2. Amaral IF, Lamghari M, Sousa SR, et al. 2005; Rat bone marrow stromal cell osteogenic differentiation and fibronectin adsorption of chitosan membranes: the effect of degree of acetylation. J Biomed Mater Res A 75A: 387-397.
3. Bale MD, Wohlfahrt LA, Mosher DF, et al. 1989; Identificaton of vitronectin as a major plasma protein adsorbed on polymer surfaces of different co-polymer composition. Blood 74: 2698-2706.
4. Bernardo ME, Faffaroni N, Novara F, et al. 2007; Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67: 9142-9149.
5. Bernards M, Qin C, Ratner B, et al. 2008; Adhesion of MC3T3-E1 cells to bone sialoprotein and bone osteopontin specifically bound to collagen I. J Biomed Mater Res A 86: 779-787.
6. Burdick J, Vunjak-Novakovic G. 2009; Engineered microenvironments for controlled stem cell differentiation. Tissue Eng A 15: 205-219.
7. Caplan A. 2007; Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
8. Cheng MY, Deng JG, Yang F, et al. 2003; Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions. Biomaterials 24: 2871-2880.
9. Chesnutt B, Yuan Y, Buddington K, et al. 2009; Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng A 15: 2571-2579.
10. Denhardt D, Noda M, O'Regan A, et al. 2001; Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061.
11. Ding CM, Zhou Y, He YH, et al. 2008; Perfusion seeding of collagen-chitosan sponges for dermal tissue engineering. Progr Biochem 43: 287-296.
12. Grayson W, Zhao F, Izadpanah R, et al. 2004; Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog 20: 905-912.
13. Helm C, Fleury E, Zisch A, et al. 2005; Synergy between interstial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci USA 102: 15779-15784.
14. Horowitz E, Gordon P, Koo W, et al. 2002; Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99: 8932-8937.
15. Horowitz E, Prockop D, Fitzpatrick L, et al. 1999; Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313.
16. Hosseinkhani H, Inatsugu Y, Hiraoka Y, et al. 2005; Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic acid) fiber. Tissue Eng 11: 1476-1488.
17. Hu PW, Leung PC, Sher A. 1996; Fluid conductance of cancellous bone graft as a predictor for graft-host interface healing. J. Biomech 29: 123-132.
18. Itoh M, Shimazu A, Hirata I, et al. 2004; Characterization of CO(3)Ap-collagen sponges using X-ray high-resolution microtomography. Biomaterials 25: 2577-2583.
19. Ivaska KK, Hentunen TA, Vaaraniemi J, et al. 2004; Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279: 18361-18369.
20. Jensen T, Dolatshahi-Pirouz A, Foss M, et al. 2010; Interaction of human mesenchymal stem cells with osteopontin coated hydroxyapatite surfaces. Colloids Surf B Biointerfaces 75: 186-193.
21. Jones A, Arns C, Hutmacher D, et al. 2009; The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 30: 1440-1451.
22. Kern S, Eichler H, Stoeve J, et al. 2006; Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
23. Kilpadi K, Chang P, Bellis S. 2001; Hydroxyapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 57: 258-267.
24. Kim HW, Kim HE, Salih V. 2006; Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials 26: 5221-5230.
25. Li Y, Ma T, Kniss DA, et al. 2001; Effects of filtration seeding on cell density, spatial distribution, and proliferation in nonwoven fibrous matrices. Biotechnol Prog 17: 935-944.
26. Murphy CM, Haugh MG, O'Brien FJ. 2010; The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 31: 461-466.
27. Ng C, Helm L, Swartz M. 2004; Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis. Microvasc Res 68: 258-264.
28. O'Brien F, Harley B, Yannas I, et al. 2005; The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26: 433-441.
29. Peter M, Ganesh N, Selvamurugan N, et al. 2010; Preparation and characterization of chitosan-gelatin/nanohydroxyapatite composite scaffolds for tissue engineering applications. Carbohydr Polym 80: 687-694.
30. Roy TD, Simon JL, Ricci JL, et al. 2003; Performance of degradable composite bone repair products made via three-dimensional fabrication techniques. J Biomed Mater Res A 66A: 283-291.
31. Salgado AJ, Oliveira JT, Pedro AJ, et al. 2006; Adult stem cells in bone and cartilage tissue engineering. Curr Stem Cell Res Ther 1: 345-364.
32. Seib FP, Prewitz M, Werner C, et al. 2009; Matrix elasticity regulates the secretory profile of human bone marrow multipotent mesenchymal stromal cells (MSCs). Biochem Biophys Res Commun 389: 663-667.
33. Semino C, Kamm R, Lauffenburger D. 2006; Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Exp Cell Res 312: 289-298.
34. Sikavitsas VI, Bancroft GN, Holtorf HL, et al. 2003; Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 100: 14683-14688.
35. Sionkowska A, Wisniewski M, Skopinska J, et al. 2004; Molecular interactions in collagen and chitosan blends. Biomaterials 25: 795-801.
36. Sundelacruz S, Kaplan D. 2009; Stem cell and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol 20: 646-655.
37. Takahashi Y, Tabata Y. 2004; Effect of fiber diameter and porosity on non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells. J Biomater Sci Polymer Ed 15: 41-57.
38. Taravel M, Domard A. 1996; Collagen and its interactions with chitosan III. Some biological and mechanical properties. Biomaterials 17: 451-455.
39. Tseng S, Lee M, Reddi A. 2008; Nonunions and the potential of stem cells in fracture healing. J Bone Joint Surg 90A: 92-98.
40. Uygun BE, Bou-Akl T, Albanna M, et al. 2010; Membrane thickness is an important variable in membrane scaffolds: influence of chitosan membrane structure on the behavior of cells. Acta Biomater 6: 2126-2131.
41. Weinreb M, Shinar D, Rodan G. 1990; Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 5: 831-842.
42. Whyte M, Kurtzberg J, McAlister W, et al. 2003; Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18: 92-98.
43. Yamane S, Iwasaki N, Kasahara Y, et al. 2007; Effect of pore size on in vitro cartilage formation using chitosan-based hyaluronic acid hybrid polmyer fibers. J Biomed Mater Res 81A: 586-593.
44. Zhao F, Grayson WL, Ma T, et al. 2006; Effects of hydroxyapatite in 3D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. Biomaterials 27: 1859-1867.
45. Zhao F, Ma T. 2005; Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng 91: 482-493.
46. Zhao F, Grayson WL, Ma T, et al. 2009; Perfusion affects the tissue development patterns of human mesenchymal stem cells in 3D scaffolds. J Cell Physiol 219: 421-429.
47. Zhao F, Yin Y, Lu WW, et al. 2002; Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite-chitosan-gelatin network composite scaffolds. Biomaterials 23: 3227-3234.